Literature DB >> 22581642

HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions.

Pushpankur Ghoshal1, Yong Teng, Leslie Ann Lesoon, John K Cowell.   

Abstract

The WASF3 (WAVE3) gene is an important mediator of cell motility, invasion and metastasis and is expressed at high levels in some advanced stage tumors. In our survey of breast cancer cells, we now demonstrate that exposure to hypoxic conditions increases WASF3 expression levels in MDA231, SKBR3 and MCF7 cells. The WASF3 promoter region contains HIF1A response elements (HRE). ChIP assays demonstrate that HIF1A binds to these HRE elements in the promoter region, and luciferase reporter assays using the WASF3 gene minimal promoter shows that hypoxia results in its upregulation. Phosphorylation of WASF3 is required for its ability to affect invasion and increased phosphoactivation of WASF3 is also seen in cells challenged with hypoxia. These cells also show increased motility in the scratch wound assay. Cells in which WASF3 has been knocked down show no response to hypoxia as expected, implicating the specificity of the hypoxic response to WASF3. Overall, these experiments demonstrate WASF3 is a HIF1A-regulated gene and suggests a mechanism to explain the observation of elevated expression of WASF3 in advanced stage tumors.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581642      PMCID: PMC3629704          DOI: 10.1002/ijc.27631

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

1.  WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression.

Authors:  Khalid Sossey-Alaoui; Tamara A Ranalli; Xiurong Li; Andrei V Bakin; John K Cowell
Journal:  Exp Cell Res       Date:  2005-08-01       Impact factor: 3.905

Review 2.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

3.  YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.

Authors:  H-L Sun; Y-N Liu; Y-T Huang; S-L Pan; D-Y Huang; J-H Guh; F-Y Lee; S-C Kuo; C-M Teng
Journal:  Oncogene       Date:  2007-01-08       Impact factor: 9.867

4.  Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.

Authors:  Veronica A Carroll; Margaret Ashcroft
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 5.  Targeting the molecular basis for tumour hypoxia.

Authors:  Veronica A Carroll; Margaret Ashcroft
Journal:  Expert Rev Mol Med       Date:  2005-04-15       Impact factor: 5.600

6.  HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.

Authors:  Michael J Gray; Jing Zhang; Lee M Ellis; Gregg L Semenza; Douglas B Evans; Stephanie S Watowich; Gary E Gallick
Journal:  Oncogene       Date:  2005-04-28       Impact factor: 9.867

Review 7.  Hypoxia signalling through mTOR and the unfolded protein response in cancer.

Authors:  Bradly G Wouters; Marianne Koritzinsky
Journal:  Nat Rev Cancer       Date:  2008-10-10       Impact factor: 60.716

8.  Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells.

Authors:  Khalid Sossey-Alaoui; Alfiya Safina; Xiurong Li; Mary M Vaughan; David G Hicks; Andrei V Bakin; John K Cowell
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

9.  Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers.

Authors:  Jen-Tsan Chi; Zhen Wang; Dimitry S A Nuyten; Edwin H Rodriguez; Marci E Schaner; Ali Salim; Yun Wang; Gunnar B Kristensen; Aslaug Helland; Anne-Lise Børresen-Dale; Amato Giaccia; Michael T Longaker; Trevor Hastie; George P Yang; Marc J van de Vijver; Patrick O Brown
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

Review 10.  The impact of O2 availability on human cancer.

Authors:  Jessica A Bertout; Shetal A Patel; M Celeste Simon
Journal:  Nat Rev Cancer       Date:  2008-11-06       Impact factor: 60.716

View more
  18 in total

1.  The WASF3-NCKAP1-CYFIP1 Complex Is Essential for Breast Cancer Metastasis.

Authors:  Yong Teng; Haiyan Qin; Abdulaziz Bahassan; N George Bendzunas; Eileen J Kennedy; John K Cowell
Journal:  Cancer Res       Date:  2016-07-18       Impact factor: 12.701

2.  Promotion of invasion by mutant RAS is dependent on activation of the WASF3 metastasis promoter gene.

Authors:  Yong Teng; Lambert Ngoka; John K Cowell
Journal:  Genes Chromosomes Cancer       Date:  2017-03-31       Impact factor: 5.006

3.  In Silico Optimized Stapled Peptides Targeting WASF3 in Breast Cancer.

Authors:  Ameya J Limaye; George N Bendzunas; Matthew K Whittaker; Timothy J LeClair; Leah G Helton; Eileen J Kennedy
Journal:  ACS Med Chem Lett       Date:  2022-03-08       Impact factor: 4.632

4.  circEXOC6B interacting with RRAGB, an mTORC1 activator, inhibits the progression of colorectal cancer by antagonizing the HIF1A-RRAGB-mTORC1 positive feedback loop.

Authors:  Xiaomin Li; Jianjun Wang; Weihao Lin; Qinzi Yuan; Yanxia Lu; Haowei Wang; Yujia Chen; Lixia Chen; Peiling Dai; Huaicheng Long; Xuenong Li
Journal:  Mol Cancer       Date:  2022-06-23       Impact factor: 41.444

5.  Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells.

Authors:  Molly A Taylor; Gangarao Davuluri; Jenny G Parvani; Barbara J Schiemann; Michael K Wendt; Edward F Plow; William P Schiemann; Khalid Sossey-Alaoui
Journal:  Breast Cancer Res Treat       Date:  2013-11-07       Impact factor: 4.872

6.  Loss of WAVE3 sensitizes triple-negative breast cancers to chemotherapeutics by inhibiting the STAT-HIF-1α-mediated angiogenesis.

Authors:  Gangarao Davuluri; William P Schiemann; Edward F Plow; Khalid Sossey-Alaoui
Journal:  JAKSTAT       Date:  2015-02-03

Review 7.  Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis.

Authors:  Khalid Sossey-Alaoui
Journal:  Semin Cell Dev Biol       Date:  2012-10-29       Impact factor: 7.727

8.  Targeting the WASF3-CYFIP1 Complex Using Stapled Peptides Suppresses Cancer Cell Invasion.

Authors:  Yong Teng; Abdulaziz Bahassan; Dayong Dong; Laura E Hanold; Xiaoou Ren; Eileen J Kennedy; John K Cowell
Journal:  Cancer Res       Date:  2015-12-16       Impact factor: 12.701

Review 9.  The involvement of JAK-STAT3 in cell motility, invasion, and metastasis.

Authors:  Yong Teng; James L Ross; John K Cowell
Journal:  JAKSTAT       Date:  2014-02-20

10.  WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells.

Authors:  Y Teng; Y Mei; L Hawthorn; J K Cowell
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.